Hot Small Cap Stocks To Buy For 2018

tags:INFU,DEST,EMR,

China’s central bank on Thursday refrained from immediately following the Federal Reserve in raising borrowing costs.

The People’s Bank of China had been widely anticipated to react to the U.S. hike by lifting the cost of reverse-repurchase agreements for the second time this year, following three increases in 2017.

“It appears the PBOC decided that growth is slowing and inflation is low and well below target, while money market rates are relatively high so they don’t want to boost them further,” said Dariusz Kowalczyk, senior emerging-market strategist at Credit Agricole SA in Hong Kong.

Chinese equities were boosted by the news. The Shanghai Composite Index erased a loss of 0.5 percent to rise 0.3 percent, while the ChiNext gauge of small caps and tech stocks led gains, climbing 0.9 percent. Government bond futures also rallied, with the most active 10-year contracts spiking 0.45 percent, the most since April 18 -- the day after the PBOC cut reserve requirement ratio. The yield on sovereign notes due in a decade was little changed at 3.68 percent as of 10:10 a.m. in Shanghai.

Hot Small Cap Stocks To Buy For 2018: InfuSystems Holdings, Inc.(INFU)

Advisors' Opinion:

• [By Logan Wallace]

  These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

  Get Scynexis alerts: Steady Activities: SCYNEXIS, Inc. (NASDAQ:SCYX), LPL Financial Holdings Inc. (NASDAQ:LPLA) (oracleexaminer.com) Do Analysts Think You Should Buy �� SCYNEXIS Inc (NASDAQ: SCYX) (stockspen.com) Notable Runner: SCYNEXIS, Inc. (SCYX) (nasdaqplace.com) Most Active Stocks Now: SCYNEXIS, Inc. (NASDAQ:SCYX), China Pharma Holdings, Inc. (NYSE:CPHI), Kala … (journalfinance.net) Overview on price to free cash flow: SCYNEXIS, Inc. (NASDAQ:SCYX), InfuSystem Holdings Inc. (NYSE:INFU) (stocksnewspoint.com)

  Several research analysts have recently issued reports on the company. Roth Capital assumed coverage on Scynexis in a research note on Tuesday, May 8th. They set a “buy” rating and a $6.00 price target for the company. Seaport Global Securities assumed coverage on Scynexis in a research note on Tuesday, April 10th. They set a “buy” rating and a $4.00 price target for the company. Zacks Investment Research raised Scynexis from a “hold” rating to a “buy” rating and set a $1.25 price target for the company in a research note on Tuesday, May 8th. HC Wainwright assumed coverage on Scynexis in a research note on Monday, May 7th. They set a “buy” rating and a $5.00 price target for the company. Finally, ValuEngine raised Scynexis from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Scynexis currently has an average rating of “Buy” and an average target price of $4.45.

• [By Joseph Griffin]

  Infusystem Holdings Inc (NYSEAMERICAN:INFU) major shareholder Meridian Ohc Partners, Lp purchased 40,548 shares of Infusystem stock in a transaction dated Monday, May 14th. The shares were acquired at an average cost of $2.76 per share, for a total transaction of $111,912.48. The transaction was disclosed in a filing with the SEC, which is available through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Hot Small Cap Stocks To Buy For 2018: Destination Maternity Corporation(DEST)

Advisors' Opinion:

• [By Alexander Bird]

  Here are last week's top-performing penny stocks:

  Penny Stock Current Share Price Last Week's Gain �Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11% Nano Dimension (Nasdaq: NNDM) $2.61 75.11% Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84% CLPS Inc. (Nasdaq: CLPS) $9.72 71.15% NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33% Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98% Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82% Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70% Polymet Mining Corp. (NYSE: PLM) $1.01 31.13% Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%

  Many investors struggle with finding stocks with this sort of breakout potential because they don't know where to look.

• [By Lisa Levin] Gainers Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares climbed 154.95 percent to close at $5.15 on Thursday. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity. Tyme Technologies, Inc. (NASDAQ: TYME) jumped 33.45 percent to close at $3.87. Universal Corporation (NYSE: UVV) gained 29.72 percent to close at $62.85 after reporting fiscal Q4 results. Evolus, Inc. (NASDAQ: EOLS) shares rose 22.93 percent to close at $23.80. nLIGHT, Inc. (NASDAQ: LASR) jumped 21.52 percent to close at $36.37 following Q1 results. Hudson Technologies Inc. (NASDAQ: HDSN) gained 20.28 percent to close at $2.61. The Cato Corporation (NYSE: CATO) shares rose 19.57 percent to close at $21.45 after the company posted better-than-expected first-quarter results. AXT, Inc. (NASDAQ: AXTI) gained 18.8 percent to close at $7.90. Catasys, Inc. (NASDAQ: CATS) rose 16.33 percent to close at $6.41. HUYA Inc. (NYSE: HUYA) rose 15.68 percent to close at $23.09 on Thursday. Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) climbed 15.11 percent to close at $6.02 on Thursday after gaining 6.30 percent on Wednesday. Baird initiated coverage on Marinus Pharmaceuticals with an Outperform rating. Destination Maternity Corporation (NASDAQ: DEST) shares rose 14.48 percent to close at $3.32 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan. China Rapid Finance Limited (NYSE: XRF) gained 11.53 percent to close at $3.29 after announcing preliminary Q1 results. Bilibili Inc.. (NASDAQ: BILI) shares rose 11.33 pe
• [By Lisa Levin] Gainers Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity. Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process. Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results. Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58. Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009. The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results. Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613. Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan. AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65. nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results. Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303. Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results. Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake. HUYA Inc. (NYSE: HUYA) gained 13.1

Hot Small Cap Stocks To Buy For 2018: Emerson Electric Company(EMR)

Advisors' Opinion:

• [By Stephan Byrd]

  Here are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

  Get Emerson Electric alerts: Stocks This Week: Wells Fargo, Emerson Electric and CSX (finance.yahoo.com) Emerson Electric (EMR) & Philips (PHG) Financial Review (americanbankingnews.com) Emerson Electric (EMR) Given Consensus Rating of “Hold” by Brokerages (americanbankingnews.com) Is It Time To Buy Emerson Electric Co (NYSE:EMR)? (finance.yahoo.com) Emerson Electric: An Autonomous Future (seekingalpha.com)

  EMR has been the topic of a number of research reports. Zacks Investment Research raised shares of Emerson Electric from a “hold” rating to a “buy” rating and set a $78.00 price objective on the stock in a research note on Thursday, February 8th. UBS initiated coverage on shares of Emerson Electric in a research note on Monday, January 22nd. They issued a “buy” rating and a $73.26 price objective on the stock. Cowen reissued a “buy” rating and issued a $78.00 price objective on shares of Emerson Electric in a research note on Wednesday, April 18th. Stifel Nicolaus increased their price objective on shares of Emerson Electric from $79.00 to $80.00 and gave the company a “buy” rating in a research note on Thursday, May 3rd. Finally, Berenberg Bank raised shares of Emerson Electric from a “sell” rating to a “hold” rating and set a $69.00 price objective on the stock in a research note on Tuesday, April 24th. They noted that the move was a valuation call. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and eight have given a buy rating to the stock. Emerson Electric has a consensus rating of “Hold” and a consensus price target of $73.00.

• [By Shane Hupp]

  Element Capital Management LLC acquired a new stake in Emerson Electric Co. (NYSE:EMR) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 202,986 shares of the industrial products company’s stock, valued at approximately $13,864,000.

• [By Benzinga News Desk]

  Former President George H.W. Bush has been hospitalized in Houston with an infection, just after attending the funeral of his wife, Barbara, a spokesman said Monday: Link

  ECONOMIC DATA Redbook Reports US Retail Sales During First 2 Weeks Of Apr. Up 0.3% MoM, Up 2.8% YoY USA S&P/CaseShiller House Price Index (MoM) for Feb Up 0.7% MoM New home sales report for March will be released at 10:00 a.m. ET. The Conference Board’s consumer sentiment index for April is schedule for release at 10:00 a.m. ET. The Richmond Fed manufacturing index for April will be released at 10:00 a.m. ET. The Treasury is set to auction 4-and 52-week bills at 11:30 a.m. ET. The Treasury will auction 2-year notes at 1:00 p.m. ET. ANALYST RATINGS Leerink upgraded Cardinal Health (NYSE: CAH) from Market Perform to Outperform Berenberg upgraded Emerson Electric (NYSE: EMR) from Sell to Hold Mizuho downgraded Skyworks (NASDAQ: SWKS) from Buy to Neutral BMO downgraded Texas Roadhouse (NASDAQ: TXRH) from Outperform to Market Perform

  This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

• [By Stephan Byrd]

  Wilkins Investment Counsel Inc. cut its stake in shares of Emerson Electric (NYSE:EMR) by 1.8% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 111,625 shares of the industrial products company’s stock after selling 2,015 shares during the quarter. Emerson Electric makes up approximately 2.4% of Wilkins Investment Counsel Inc.’s portfolio, making the stock its 17th biggest position. Wilkins Investment Counsel Inc.’s holdings in Emerson Electric were worth $7,624,000 at the end of the most recent reporting period.

• [By Lee Samaha]

  In common with many other industrial companies, like Danaher, Pentair has been taking action to become a more focused investment proposition for investors. The sale of its valves and controls business to Emerson Electric (NYSE:EMR) in the spring of 2017 turned out to be well-timed for Emerson, as it occurred precisely at the time when oil and gas capital spending started picking up.